GlobeNewswire: Sucampo Pharmaceuticals Inc Contains the last 10 of 150 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T12:18:20ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2017/11/27/1206570/0/en/Sucampo-Pharmaceuticals-Announces-its-Participation-at-the-Global-Mizuho-Investor-Conference.html?f=22&fvtc=4&fvtv=19741Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference2017-11-27T21:10:00Z<![CDATA[ROCKVILLE, Md., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in investor meetings at the Global Mizuho Investor Conference on Monday, December 4, 2017 in New York.]]>https://www.globenewswire.com/news-release/2017/11/21/1198317/0/en/Sucampo-Pharmaceuticals-Announces-Webcast-of-Its-Presentation-at-the-29th-Annual-Piper-Jaffray-Healthcare-Conference.html?f=22&fvtc=4&fvtv=19741Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 29th Annual Piper Jaffray Healthcare Conference2017-11-21T21:10:00Z<![CDATA[ROCKVILLE, Md., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside chat at the 29th Annual Piper Jaffray Healthcare Conference on Tuesday, November 28th at 11:30AM Eastern.]]>https://www.globenewswire.com/news-release/2017/11/09/1179042/0/en/Sucampo-to-Host-2017-R-D-Day-on-November-16-in-New-York.html?f=22&fvtc=4&fvtv=19741Sucampo to Host 2017 R&D Day on November 16 in New York2017-11-09T22:48:23Z<![CDATA[Event to be Webcast Event to be Webcast]]>https://www.globenewswire.com/news-release/2017/11/01/1172068/0/en/Sucampo-Reports-Third-Quarter-2017-Financial-Results.html?f=22&fvtc=4&fvtv=19741Sucampo Reports Third Quarter 2017 Financial Results2017-11-01T10:30:00Z<![CDATA[Company Increases 2017 Financial Guidance Based on Strong Performance Year to Date]]>https://www.globenewswire.com/news-release/2017/10/23/1151804/0/en/Sucampo-Announces-Third-Quarter-2017-Earnings-Call.html?f=22&fvtc=4&fvtv=19741Sucampo Announces Third Quarter 2017 Earnings Call2017-10-23T20:05:00Z<![CDATA[ROCKVILLE, Md., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its third quarter 2017 financial results teleconference and webcast at 8:30 a.m. Eastern on Wednesday, November 1st. The press release announcing the financial results and operating highlights is expected to be released before the opening of capital markets that day.]]>https://www.globenewswire.com/news-release/2017/09/28/1134664/0/en/Sucampo-Pharmaceuticals-Announces-FDA-Acceptance-of-sNDA-for-AMITIZA-in-Children-with-Pediatric-Functional-Constipation-with-Priority-Review-Designation.html?f=22&fvtc=4&fvtv=19741Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with Priority Review Designation2017-09-28T21:34:26Z<![CDATA[ROCKVILLE, Md., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its recently submitted supplemental New Drug Application (sNDA) for lubiprostone (AMITIZA®) in children aged 6 to 17 years with pediatric functional constipation. The filing has received Priority Review designation from the FDA.]]>https://www.globenewswire.com/news-release/2017/09/28/1133984/0/en/Sucampo-Pharmaceuticals-Announces-Presentation-at-Deutsche-Bank-s-25th-Annual-Leveraged-Finance-Conference.html?f=22&fvtc=4&fvtv=19741Sucampo Pharmaceuticals Announces Presentation at Deutsche Bank’s 25th Annual Leveraged Finance Conference2017-09-28T00:43:21Z<![CDATA[ROCKVILLE, Md., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that the company will participate in Deutsche Bank’s 25th Annual Leveraged Finance Conference on Wednesday, October 4th at 2:15PM Mountain.]]>https://www.globenewswire.com/news-release/2017/09/21/1125854/0/en/Sucampo-Pharmaceuticals-Announces-Webcast-of-Its-Presentation-at-the-2017-Leerink-Partners-Roundtable-Series-Rare-Disease-Immuno-Oncology.html?f=22&fvtc=4&fvtv=19741Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology2017-09-21T12:25:00Z<![CDATA[ROCKVILLE, Md., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside chat at the 2017 Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology on Wednesday, September 27th at 3:30PM Eastern.]]>https://www.globenewswire.com/news-release/2017/09/20/1125497/0/en/Sucampo-Pharmaceuticals-Appoints-Alex-Driggs-as-General-Counsel.html?f=22&fvtc=4&fvtv=19741Sucampo Pharmaceuticals Appoints Alex Driggs as General Counsel2017-09-20T20:15:00Z<![CDATA[ROCKVILLE, Md., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the appointment of Alex Driggs to General Counsel and Corporate Secretary. Mr. Driggs joined Sucampo in May 2015 as Associate General Counsel, was appointed its Deputy General Counsel in September 2015, and has most recently served as Acting General Counsel and Corporate Secretary since June 2017.]]>https://www.globenewswire.com/news-release/2017/09/19/1124901/0/en/Sucampo-Pharmaceuticals-Announces-Webcast-of-Its-Presentation-at-the-2017-Cantor-Fitzgerald-Global-Healthcare-Conference.html?f=22&fvtc=4&fvtv=19741Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Cantor Fitzgerald Global Healthcare Conference2017-09-19T20:15:00Z<![CDATA[ROCKVILLE, Md., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the 2017 Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26th at 11:30AM Eastern.]]>